Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 64,39 mln. 68,88 mln. | Omzet 2024 * | 73,53 mln. 78,65 mln. | Marktkapitalisatie | 62,48 mln. 66,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -39 mln. -41,72 mln. | Nettowinst (verlies) 2024 * | -26 mln. -27,81 mln. | EV/omzet 2023 | 1,51 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 0,85 x |
K/w-verhouding 2023 |
-2,37
x | K/w-verhouding 2024 * |
-2,44
x | Werknemers | 255 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 97,37% |
Recentste transcriptie over MDxHealth SA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,13% | 43,43 mld. | |
+48,83% | 41,69 mld. | |
+8,49% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,26% | 25,28 mld. | |
-23,69% | 18,47 mld. | |
+1,58% | 12,33 mld. | |
+32,83% | 12,59 mld. | |
+6,63% | 11,03 mld. |